Biomarin Pharmaceutical - Registered Shares Overview
Biomarin Pharmaceutical - Registered Shares Target Price
See Biomarin Pharmaceutical - Registered Shares's analyst price targets ($91) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$65.08
Average Target Price
$90.50
39.1% upside
39.1% upside18 analysts in the last 4 months
High: $124 | Low: $50
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-01 | Cantor Fitzgerald | $86 | 32.1% upside |  |
| 2026-09-01 | Piper Sandler | $90 | 38.3% upside | |
| 2026-08-31 | JefferiesAkash Tewari | $105 | 61.3% upside | |
| 2026-08-31 | Raymond James | $109 | 67.5% upside | |
| 2026-08-26 | UBS | $88 | 35.2% upside | |
| 2026-08-18 | BMO CapitalDavid Lebowitz | $98 | 50.6% upside | |
| 2026-08-18 | H.C. Wainwright | $59 |  9.3% downside | |
| 2026-08-17 | Piper Sandler | $88 | 35.2% upside | |
| 2026-08-17 | BarclaysEliana Merle | $111 | 70.6% upside | |
| 2026-08-10 | Canaccord GenuityWhitney Ijem | $114 | 75.2% upside | |
| 2026-08-07 | Raymond James | $105 | 61.3% upside | |
| 2026-08-07 | Morgan Stanley | $124 | 90.5% upside | |
| 2026-08-07 | Stifel Nicolaus | $70 | 7.6% upside | |
| 2026-08-07 | OppenheimerLeland Gershell | $97 | 49% upside | |
| 2026-07-07 | RBC CapitalLuca Issi | $62 | 4.7% downside | |
| 2026-05-22 | Canaccord Genuity | $111 | 70.6% upside | |
| 2026-05-18 | Leerink Partners | $62 | 4.7% downside | |
| 2026-05-18 | H.C. Wainwright | $50 | 23.2% downside | |
| 2026-05-11 | Goldman Sachs | $69 | 6% upside | |
| 2026-05-05 | Evercore ISI | $120 | 84.4% upside | |
| 2026-05-05 | Tudor PickeringWilliam Pickering | $82 | 26% upside | |
| 2026-04-27 | Morgan StanleySean Laaman | $120 | 84.4% upside | |
| 2026-03-12 | JefferiesAkash Tewari | $103 | 58.3% upside | |
| 2026-03-03 | BarclaysEliana Merle | $105 | 61.3% upside | |
| 2026-03-02 | Loop Capital MarketsIlya Zubkov | $105 | 61.3% upside | |
| 2026-02-26 | Canaccord GenuityWhitney Ijem | $104 | 59.8% upside | |
| 2026-02-24 | Oppenheimer | $95 | 46% upside | |
| 2026-02-24 | Stifel NicolausPaul Matteis | $68 | 4.5% upside | |
| 2026-02-18 | Wells Fargo | $75 | 15.2% upside | |
| 2026-02-06 | Piper Sandler | $84 | 29.1% upside | |
| 2026-01-20 | Canaccord Genuity | $98 | 50.6% upside | |
| 2025-12-23 | Truist FinancialJoon Lee | $100 | 53.7% upside | |
| 2025-12-22 | H.C. Wainwright | $60 | 7.8% downside | |
| 2025-12-03 | Leerink Partners | $60 | 7.8% downside | |
| 2025-11-03 | Tudor PickeringWilliam Pickering | $88 | 35.2% upside | |
| 2025-11-03 | Bernstein | $88 | 35.2% upside | |
| 2025-10-28 | RBC CapitalLuca Issi | $66 | 1.4% upside | |
| 2025-10-28 | Stifel Nicolaus | $73 | 12.2% upside | |
| 2025-10-28 | Truist FinancialJoon Lee | $80 | 22.9% upside | |
| 2025-10-28 | Morgan StanleySean Laaman | $98 | 50.6% upside | |
| 2025-10-28 | H.C. Wainwright | $55 | 15.5% downside | |
| 2025-10-28 | Wells FargoMohit Bansal | $70 | 7.6% upside | |
| 2025-10-28 | Barclays | $80 | 22.9% upside | |
| 2025-08-05 | UBS | $114 | 75.2% upside | |
| 2025-07-15 | Wolfe ResearchAkash Tewari | $95 | 46% upside | |
| 2024-10-30 | Cantor FitzgeraldOlivia Brayer | $90 | 38.3% upside | |
| 2024-10-30 | Robert W. BairdJack Allen | $65 | 0.1% downside | |
| 2024-10-30 | CitigroupDavid Lebowitz | $81 | 24.5% upside | |
| 2024-10-10 | Raymond JamesDanielle Brill | $79 | 21.4% upside | |
| 2024-10-04 | BarclaysGena Wang | $86 | 32.1% upside | |